GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » The Flowr Corp (TSXV:FLWR.H) » Definitions » Loans Receivable

The Flowr (TSXV:FLWR.H) Loans Receivable : C$0.00 Mil (As of Sep. 2022)


View and export this data going back to 2017. Start your Free Trial

What is The Flowr Loans Receivable?

The Flowr's Loans Receivable for the quarter that ended in Sep. 2022 was C$0.00 Mil.


The Flowr Loans Receivable Historical Data

The historical data trend for The Flowr's Loans Receivable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

The Flowr Loans Receivable Chart

The Flowr Annual Data
Trend Jun17 Jun18 Dec19 Dec20 Dec21
Loans Receivable
- - - - -

The Flowr Quarterly Data
Sep17 Mar18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22
Loans Receivable Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

The Flowr Loans Receivable Calculation

Loans Receivable are the funds that a company has lent but have not yet been repaid.


The Flowr Loans Receivable Related Terms

Thank you for viewing the detailed overview of The Flowr's Loans Receivable provided by GuruFocus.com. Please click on the following links to see related term pages.


The Flowr (TSXV:FLWR.H) Business Description

Traded in Other Exchanges
N/A
Address
9590 McCarthy Road, Kelowna, BC, CAN, V4V 1R2
The Flowr Corp is a Toronto-headquartered cannabis company with operations in Canada and Europe. Its Canadian operating campus, located in Kelowna, BC, includes a purpose-built, GMP-designed indoor cultivation facility; an outdoor and greenhouse cultivation site; and a R&D facility that is awaiting licensing from Health Canada. From this campus, Flowr produces recreational and medicinal products. Internationally, it intends to service the global medical cannabis market through its subsidiary Holigen, which has a license for cannabis cultivation in Portugal and operates GMP licensed facilities in Portugal.

The Flowr (TSXV:FLWR.H) Headlines

No Headlines